When Patients Lead, Outcomes Improve
A cancer diagnosis brings more than medical decisions—it brings fear, uncertainty, and often, a feeling of lost control. But when people are invited to lead their treatment decisions, everything shifts. At Ardynn, we hear it all the time: “I didn’t know I could say no.”“I just wanted someone to explain it in a way that […]
When Treatment Reflects What Matters Most
After a cancer diagnosis, one of the first things many people hear is a list of treatment options. Surgery. Chemo. Radiation. Targeted therapy. Each comes with its own risks, benefits, and tradeoffs. But what’s often missing in these conversations is the question:What matters most to you? One of our members, a 67-year-old man living with […]
Confronting Racial Disparities in Cancer Care
Not everyone experiences cancer the same way. While the disease itself doesn’t discriminate, the systems surrounding diagnosis, treatment, and support too often do. Racial disparities in cancer care are a longstanding and unacceptable reality—affecting when cancer is found, what treatments are offered, and ultimately, who survives. This isn’t just a question of fairness. It’s a […]
The Benefits of Shared Decision Making in Healthcare
In the realm of healthcare, shared decision-making (SDM) has emerged as a transformative approach that empowers patients to actively participate in their care journey alongside healthcare professionals. This collaborative process involves patients, their families, and healthcare providers working together to make informed decisions that align with patients’ values, preferences, and unique circumstances. In this blog […]
Is Colon Cancer Really Rising in Young People?
In recent years, there has been an apparent increase in the incidence of colon cancer among young adults. Colon cancer has traditionally been considered a disease that affects older people. This topic has sparked much debate, speculation, research, and media coverage. But the question remains: Is colon cancer really on the rise among young people? […]
HPV is a Risk Factor for More than Just Cervical Cancer
Human Papillomavirus (HPV) is a common sexually transmitted infection that has been primarily associated with cervical cancer. However, HPV is a risk factor for a wide range of other cancers and health conditions, making it essential to raise awareness about its broader impact on health for both men and women. What is HPV? HPV is […]
Why Social Support Matters in Cancer Care
Cancer affects millions of people worldwide, not just physically, but emotionally and psychologically as well. The journey through cancer diagnosis, treatment, and recovery can be an incredibly challenging one, often accompanied by feelings of fear, uncertainty, and isolation. During this difficult time, social support is immensely important. Social support, provided by family, friends, and healthcare […]
Why April Matters: Testicular Cancer Awareness Month
The month of April is recognized as Testicular Cancer Awareness Month, a time to raise awareness about this important issue and encourage men to take charge of their health. Here at Ardynn, we understand the impact that cancer can have on individuals and their families. That’s why we’re committed to spreading awareness and educating others […]
The Benefits of Shared Decision-Making
Making the most informed treatment decisions is vital for new patients and their families. Shared decision-making allows patients to have a say in their treatment methods while also allowing healthcare professionals to provide the best individualized treatment possible. Because nobody knows a patient better than themselves, allowing patients a voice in their care can change […]
Sweden Leads The Way In Monitoring Low-Risk Prostate Cancer Through Active Surveillance
On November 17th, specialists from the Netherlands, the United Kingdom, and Michigan discussed their methods for achieving very high levels of active monitoring during a webinar hosted by the Active Surveillance Coalition. Although active surveillance has been shown to prevent prostate cancer overtreatment, most nations still neglect it. According to American models, cost-effective prostate […]